GVR Report cover Local Anesthesia Drugs Market Size, Share & Trends Report

Local Anesthesia Drugs Market Size, Share & Trends Analysis Report By Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application, And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-2-68038-086-6
  • Number of Pages: 90
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2015
  • Industry: Healthcare

Industry Insights

The local anesthesia drugs market size was valued at USD 4.65 billion in 2016 and is expected to expand at a CAGR of 3.7% over the forecast period. There has been an increase in the number of surgical procedures performed across the globe, including dental procedures, cosmetic surgeries, and plastic surgeries. This is a major factor driving the market for local anesthetics.

A key trend observed in the market is a significant rise in demand for post-operative pain relief options, on the heels of an increasing number of surgical procedures. This trend is likely to continue throughout the forecast period, positively influencing the demand for local anesthesia drugs. An approximate 65.0% of the total surgical procedures performed need postoperative pain management.

U.S. local anesthesia drugs market

Growth in the number of surgeries performed can be attributed to the aging population, a demographic group that is more prone to chronic diseases such as cardiovascular disorders, respiratory ailments, cancer, neurological disorders, and other gastro, orthopedic, and spinal problems. Advancements in drug delivery technologies are also expected to contribute to the demand for local anesthetics in surgical procedures. For instance, DepoFoam technology uses a new method to deliver bupivacaine and is very efficient in the management of post-operative pain.

The growth of the market for local anesthesia drugs is also fueled by the introduction of new and effective drugs such as articaine, levobupivacaine, and ropivacaine. This growth is supplemented by increasing healthcare expenditure in developing countries such as India, China, and Brazil, where the number of surgeries performed has been on a steady rise.

Product Insights

On the basis of product, the local anesthesia drugs market has been segmented into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and other local anesthetics. The lidocaine drug dominated the market in 2016 owing to its extensive use as a topical and injectable anesthetic. The entry of newer drugs such as articaine and bupivacaine will, however, threaten to challenge the market share of this drug over the forecast period.

Bupivacaine is expected to witness the fastest growth through 2025 due to a significant number of clinical trials conducted on the drug as of 2016. The growth is also attributed to its extensive use in postoperative pain management. Drugs such as ropivacaine and articaine are also expected to witness promising growth over the forecast period.

Application Insights

In terms of application, the market for local anesthesia drugs has been bifurcated into injectable and surface anesthetics. By way of revenue, the injectable anesthetics segment dominated the market and this trend is likely to continue during the forecast period. This is primarily attributed to the extensive usage of injectable anesthetics in different surgical procedures. Surface anesthetics, on the other hand, are anticipated to witness the fastest growth over the forecast period. Advancements in drug delivery systems are expected to be the key driving factor for this segment.

Regional Insights

North America held the largest share in the market owing to a significant number of surgical procedures performed in the U.S. The country accounts for more than 25.0% of surgical procedures performed across the globe. High per capita income, improved access to healthcare, an increase in the prevalence of chronic diseases, and rising geriatric population are driving the market for local anesthesia drugs in this region.

Global local anesthesia drugs market

Europe held the second-largest share as of 2016 and is expected to witness decent growth during the forecast period. The growth is attributed to the increasing volume of dental and cosmetic surgeries, advancements in surgical procedures, and growing use of local anesthetics in post-operative pain management.

The Asia Pacific and Latin American markets are expected to exhibit lucrative growth over the forecast period owing to expanding geriatric population, which is anticipated to drive the number of surgical procedures performed in the region. The decline in opioid use in the region is also expected to contribute to market growth.

Local Anesthesia Drugs Market Share Insights

Some of the key players in the market for local anesthesia drugs are Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and Teva Pharmaceuticals. There are numerous regional and local generic players in the market, which makes the market increasingly competitive. GlaxoSmithKline and AstraZeneca recently divested their anesthesia portfolio to Aspen Pharmacare, making Aspen one of the largest suppliers of anesthesia drugs across the globe.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2015

Forecast period

2017 - 2025

Market representation

Revenue in USD Million & CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, & MEA

Country scope

U.S., Canada, U.K., Germany, France, Japan, China, Brazil, Mexico, and South Africa

Report coverage

Revenue, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the local anesthesia drugs market report on the basis of product, application, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Bupivacaine

    • Ropivacaine

    • Lidocaine

    • Chloroprocaine

    • Prilocaine

    • Benzocaine

    • Other local anesthetics

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Injectable

    • Surface Anesthetic

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The U.K.

    • Asia Pacific

      • China

      • Japan

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.